-
1
-
-
0015694748
-
A new consistent chromosome abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining
-
Rowley JD. (1973) A new consistent chromosome abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:209-13.
-
(1973)
Nature
, vol.243
, pp. 209-13
-
-
Rowley, J.D.1
-
2
-
-
0037114753
-
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
-
Byrd JC, Mrozek K, Dodge RK, et al. (2002) Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 100:4325-36.
-
(2002)
Blood
, vol.100
, pp. 4325-36
-
-
Byrd, J.C.1
Mrozek, K.2
Dodge, R.K.3
-
3
-
-
19944427850
-
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype
-
Falini B, Mecucci C, Tiacci E, et al. (2005) Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. New Engl J Med 352:254-66.
-
(2005)
New Engl J Med
, vol.352
, pp. 254-66
-
-
Falini, B.1
Mecucci, C.2
Tiacci, E.3
-
4
-
-
0141465061
-
The role of FLT3 in haematopoietic malignancies
-
Stirewalt DL, Radich JP. (2003) The role of FLT3 in haematopoietic malignancies. Nature Reviews 3:650-65.
-
(2003)
Nature Reviews
, vol.3
, pp. 650-65
-
-
Stirewalt, D.L.1
Radich, J.P.2
-
5
-
-
64849100299
-
Molecular genetic pathways as therapeutic targets in acute myeloid leukemia
-
2008
-
Haferlach T. (2008) Molecular genetic pathways as therapeutic targets in acute myeloid leukemia. Hematology 2008:400-11.
-
(2008)
Hematology
, pp. 400-11
-
-
Haferlach, T.1
-
6
-
-
0034890863
-
Hematologic malignancies
-
Gilliland DG. (2001) Hematologic malignancies. Curr Opin Hematol 8:189-91.
-
(2001)
Curr Opin Hematol
, vol.8
, pp. 189-91
-
-
Gilliland, D.G.1
-
7
-
-
0032523142
-
Acute promyelocytic leukemia: relieving repression induces remission
-
Collins SJ. (1998) Acute promyelocytic leukemia: relieving repression induces remission. Blood 91:2631-3.
-
(1998)
Blood
, vol.91
, pp. 2631-3
-
-
Collins, S.J.1
-
8
-
-
0028179425
-
PLZF-RAR alpha fusion proteins generated from the variant t (11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors
-
USA
-
Chen Z, Guidez F, Rousselot P, et al. (1994) PLZF-RAR alpha fusion proteins generated from the variant t (11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc Natl Acad SciU S A 91:1178-82.
-
(1994)
Proc Natl Acad Sci
, vol.91
, pp. 1178-82
-
-
Chen, Z.1
Guidez, F.2
Rousselot, P.3
-
9
-
-
0030022316
-
The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion
-
Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ. (1996) The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 87:882-6.
-
(1996)
Blood
, vol.87
, pp. 882-6
-
-
Redner, R.L.1
Rush, E.A.2
Faas, S.3
Rudert, W.A.4
Corey, S.J.5
-
10
-
-
0030771192
-
Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia
-
Wells RA, Catzavelos C, Kamel-Reid S. (1997) Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nat Genet 17:109-13.
-
(1997)
Nat Genet
, vol.17
, pp. 109-13
-
-
Wells, R.A.1
Catzavelos, C.2
Kamel-Reid, S.3
-
11
-
-
0032867588
-
The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia
-
Arnould C, Philippe C, Bourdon V, et al. (1999) The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia.HumMol Genet 8:1741-9.
-
(1999)
HumMol Gene
, vol.8
, pp. 1741-9
-
-
Arnould, C.1
Philippe, C.2
Bourdon, V.3
-
12
-
-
0037169341
-
The role of PML in tumor suppression
-
Salomoni P, Pandolfi P.P. (2002) The role of PML in tumor suppression. Cell 108:165-70.
-
(2002)
Cell
, vol.108
, pp. 165-70
-
-
Salomoni, P.1
Pandolfi, P.P.2
-
13
-
-
0036636857
-
Core-binding factors in haematopoiesis and leukaemia
-
Speck NA, Gilliland DG. (2002) Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2:502-13.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 502-13
-
-
Speck, N.A.1
Gilliland, D.G.2
-
14
-
-
9544257262
-
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia
-
Jurlander J, Caligiuri MA, Ruutu T, et al. (1996) Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood 88:2183-91.
-
(1996)
Blood
, vol.88
, pp. 2183-91
-
-
Jurlander, J.1
Caligiuri, M.A.2
Ruutu, T.3
-
15
-
-
0027317604
-
Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission
-
Nucifora G, Larson RA, Rowley JD. (1993) Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 82:712-5.
-
(1993)
Blood
, vol.82
, pp. 712-5
-
-
Nucifora, G.1
Larson, R.A.2
Rowley, J.D.3
-
16
-
-
31444447072
-
Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement
-
Shih LY, Liang DC, Fu JF, et al. (2006) Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia 20:218-23.
-
(2006)
Leukemia
, vol.20
, pp. 218-23
-
-
Shih, L.Y.1
Liang, D.C.2
Fu, J.F.3
-
17
-
-
0141816710
-
AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases
-
Schoch C, Schnittger S, Klaus M, et al. (2003) AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 102:2395-402.
-
(2003)
Blood
, vol.102
, pp. 2395-402
-
-
Schoch, C.1
Schnittger, S.2
Klaus, M.3
-
18
-
-
70350497118
-
Novel prognostic subgroups in childhood 11q23/MLLrearranged acute myeloid leukemia: results of an international retrospective study
-
Balgobind BV, Raimondi SC, Harbott J, et al. (2009) Novel prognostic subgroups in childhood 11q23/MLLrearranged acute myeloid leukemia: results of an international retrospective study. Blood 114:2489-96.
-
(2009)
Blood
, vol.114
, pp. 2489-96
-
-
Balgobind, B.V.1
Raimondi, S.C.2
Harbott, J.3
-
19
-
-
0036682174
-
Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm
-
Dohner K, Tobis K, Ulrich R, et al. (2002) Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. J Clin Oncol 20:3254-61.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3254-61
-
-
Dohner, K.1
Tobis, K.2
Ulrich, R.3
-
20
-
-
0032519768
-
c-kit ligand and FLT3 ligand: stem/progenitor cell factors with overlapping yet distinct activities
-
Lyman SD, Jacobsen SE. (1998) c-kit ligand and FLT3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 91:1101-34.
-
(1998)
Blood
, vol.91
, pp. 1101-34
-
-
Lyman, S.D.1
Jacobsen, S.E.2
-
21
-
-
0024376173
-
Ras oncogenes in human cancer: a review
-
Bos JL. (1989) Ras oncogenes in human cancer: a review. Cancer Res 49:4682-9.
-
(1989)
Cancer Res
, vol.49
, pp. 4682-9
-
-
Bos, J.L.1
-
23
-
-
0030992130
-
Protein prenylation, et cetera: signal transduction in two dimensions
-
Gelb MH. (1997) Protein prenylation, et cetera: signal transduction in two dimensions. Science 275:1750-1.
-
(1997)
Science
, vol.275
, pp. 1750-1
-
-
Gelb, M.H.1
-
24
-
-
0029926755
-
Signaling by the cytokine receptor superfamily in normal and transformed hematopoietic cells
-
Ihle JN. (1996) Signaling by the cytokine receptor superfamily in normal and transformed hematopoietic cells. Adv Can Res 68:23-65.
-
(1996)
Adv Can Res
, vol.68
, pp. 23-65
-
-
Ihle, J.N.1
-
25
-
-
0028964465
-
Cytokine signaling through nonreceptor protein tyrosine kinases
-
Taniguchi T. (1995) Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251-5.
-
(1995)
Science
, vol.268
, pp. 251-5
-
-
Taniguchi, T.1
-
26
-
-
15444339209
-
A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
-
Lacronique V, Boureux A, Valle VD, et al. (1997) A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278:1309-12.
-
(1997)
Science
, vol.278
, pp. 1309-12
-
-
Lacronique, V.1
Boureux, A.2
Valle, V.D.3
-
27
-
-
0034660463
-
Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6
-
Schuringa JJ, Wierenga AT, Kruijer W, Vellenga E. (2000) Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6. Blood 95:3765-70.
-
(2000)
Blood
, vol.95
, pp. 3765-70
-
-
Schuringa, J.J.1
Wierenga, A.T.2
Kruijer, W.3
Vellenga, E.4
-
28
-
-
0035203382
-
Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts
-
Birkenkamp KU, Geugien M, Lemmink HH, Kruijer W, Vellenga E. (2001) Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts. Leukemia 15:1923-31.
-
(2001)
Leukemia
, vol.15
, pp. 1923-31
-
-
Birkenkamp, K.U.1
Geugien, M.2
Lemmink, H.H.3
Kruijer, W.4
Vellenga, E.5
-
29
-
-
0031686409
-
Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product
-
Kiyoi H, Towatari M, Yokota S, et al. (1998) Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia 12:1333-7.
-
(1998)
Leukemia
, vol.12
, pp. 1333-7
-
-
Kiyoi, H.1
Towatari, M.2
Yokota, S.3
-
30
-
-
0030451722
-
Internal tandem duplication of the FLT3 gene found in acute myeloid leukemia
-
Nakao M, Yokota S, Iwai T, et al. (1996) Internal tandem duplication of the FLT3 gene found in acute myeloid leukemia. Leukemia 10:1911-8.
-
(1996)
Leukemia
, vol.10
, pp. 1911-8
-
-
Nakao, M.1
Yokota, S.2
Iwai, T.3
-
31
-
-
65449158845
-
Anovel molecular mechanism of primary resistance to FLT3-kinase inhibitors in AML
-
Breitenbuecher F, Markova B, Kasper S, et al. (2009) Anovel molecular mechanism of primary resistance to FLT3-kinase inhibitors in AML. Blood 113:4063-73.
-
(2009)
Blood
, vol.113
, pp. 4063-73
-
-
Breitenbuecher, F.1
Markova, B.2
Kasper, S.3
-
32
-
-
70350504884
-
Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome
-
Kayser S, Schlenk RF, Londono MC, et al. (2009) Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome. Blood 114:2386-92.
-
(2009)
Blood
, vol.114
, pp. 2386-92
-
-
Kayser, S.1
Schlenk, R.F.2
Londono, M.C.3
-
33
-
-
0034936404
-
Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia
-
Abu-Duhier FM, Goodeve AC, Wilson GA, et al. (2001) Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia. Br J Haematol 113:983-8.
-
(2001)
Br J Haematol
, vol.113
, pp. 983-8
-
-
Abu-Duhier, F.M.1
Goodeve, A.C.2
Wilson, G.A.3
-
34
-
-
0035871889
-
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
-
Yamamoto Y, Kiyoi H, Nakano Y, et al. (2001) Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 97:2434-9.
-
(2001)
Blood
, vol.97
, pp. 2434-9
-
-
Yamamoto, Y.1
Kiyoi, H.2
Nakano, Y.3
-
35
-
-
36649000489
-
Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles
-
Frohling S, Scholl C, Levine RL, et al. (2007) Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles. Cancer Cell 12:501-13.
-
(2007)
Cancer Cell
, vol.12
, pp. 501-13
-
-
Frohling, S.1
Scholl, C.2
Levine, R.L.3
-
36
-
-
34547120985
-
Arginine 595 is duplicated in patients with acute leukemias carrying internal tandem duplications of FLT3 and modulates its transforming potential
-
Vempati S, Reindl C, Kaza SK, et al. (2007) Arginine 595 is duplicated in patients with acute leukemias carrying internal tandem duplications of FLT3 and modulates its transforming potential. Blood 110:686-94.
-
(2007)
Blood
, vol.110
, pp. 686-94
-
-
Vempati, S.1
Reindl, C.2
Kaza, S.K.3
-
38
-
-
0001097136
-
Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic mye- logenous leukaemia in children
-
Xu F, Taki T, Yang HW, et al. (1999) Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic mye- logenous leukaemia in children. Br J Haematol 105:155-62.
-
(1999)
Br J Haematol
, vol.105
, pp. 155-62
-
-
Xu, F.1
Taki, T.2
Yang, H.W.3
-
39
-
-
0035383768
-
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia
-
Stirewalt DL, Kopecky KJ, Meshinchi S, et al. (2001) FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia. Blood 97:3589-95.
-
(2001)
Blood
, vol.97
, pp. 3589-95
-
-
Stirewalt, D.L.1
Kopecky, K.J.2
Meshinchi, S.3
-
40
-
-
0035168677
-
Prevalence and prognostic significance of FLT3 internal tandem duplication in pediatric acute myeloid leukemia
-
Meshinchi S, Woods WG, Stirewalt DL, et al. (2001) Prevalence and prognostic significance of FLT3 internal tandem duplication in pediatric acute myeloid leukemia. Blood 97:89-94.
-
(2001)
Blood
, vol.97
, pp. 89-94
-
-
Meshinchi, S.1
Woods, W.G.2
Stirewalt, D.L.3
-
41
-
-
0036659931
-
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease
-
Schnittger S, Schoch C, Dugas M, et al. (2002) Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 100:59-66.
-
(2002)
Blood
, vol.100
, pp. 59-66
-
-
Schnittger, S.1
Schoch, C.2
Dugas, M.3
-
42
-
-
0037097716
-
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
-
Thiede C, Steudel C, Mohr B, et al. (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99:4326-35.
-
(2002)
Blood
, vol.99
, pp. 4326-35
-
-
Thiede, C.1
Steudel, C.2
Mohr, B.3
-
43
-
-
0033758958
-
FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group
-
Abu-Duhier FM, Goodeve AC, Wilson GA, et al. (2000) FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group. Br J Haematol 111(1):190-5.
-
(2000)
Br J Haematol
, vol.111
, Issue.1
, pp. 190-5
-
-
Abu-Duhier, F.M.1
Goodeve, A.C.2
Wilson, G.A.3
-
44
-
-
0033134792
-
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia
-
Kiyoi H, Naoe T, Nakano Y, et al. (1999) Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 93:3074-80.
-
(1999)
Blood
, vol.93
, pp. 3074-80
-
-
Kiyoi, H.1
Naoe, T.2
Nakano, Y.3
-
45
-
-
0035885955
-
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
-
Kottaridis PD, Gale RE, Frew ME, et al. (2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 98:1752-9.
-
(2001)
Blood
, vol.98
, pp. 1752-9
-
-
Kottaridis, P.D.1
Gale, R.E.2
Frew, M.E.3
-
46
-
-
0032931560
-
Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia
-
Iwai T, Yokota S, Nakao M, et al. (1999) Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan. Leukemia 13:38-43.
-
(1999)
The Children's Cancer and Leukemia Study Group, Japan. Leukemia
, vol.13
, pp. 38-43
-
-
Iwai, T.1
Yokota, S.2
Nakao, M.3
-
47
-
-
0032757551
-
Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia
-
Kondo M, Horibe K, Takahashi Y, et al. (1999) Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia. Med Pediatr Oncol 33:525-9.
-
(1999)
Med Pediatr Oncol
, vol.33
, pp. 525-9
-
-
Kondo, M.1
Horibe, K.2
Takahashi, Y.3
-
48
-
-
0035476264
-
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study
-
Whitman SP, Archer KJ, Feng L, et al. (2001) Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res 61:7233-9.
-
(2001)
Cancer Res
, vol.61
, pp. 7233-9
-
-
Whitman, S.P.1
Archer, K.J.2
Feng, L.3
-
49
-
-
0036786289
-
Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse
-
Shih LY, Huang CF, Wu JH, et al. (2002) Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse. Blood 100:2387-92.
-
(2002)
Blood
, vol.100
, pp. 2387-92
-
-
Shih, L.Y.1
Huang, C.F.2
Wu, J.H.3
-
50
-
-
0036850573
-
Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol
-
Noguera NI, Breccia M, Divona M, et al. (2002) Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol. Leukemia 16:2185-9.
-
(2002)
Leukemia
, vol.16
, pp. 2185-9
-
-
Noguera, N.I.1
Breccia, M.2
Divona, M.3
-
51
-
-
0036659931
-
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease
-
Schnittger S, Schoch C, DugasM,et al. (2002) Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 100:59-66.
-
(2002)
Blood
, vol.100
, pp. 59-66
-
-
Schnittger, S.1
Schoch, C.2
Dugas, M.3
-
52
-
-
33646431111
-
Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia
-
Stirewalt DL, Kopecky KJ, Meshinchi S, et al. (2006) Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia. Blood 107:3724-6.
-
(2006)
Blood
, vol.107
, pp. 3724-6
-
-
Stirewalt, D.L.1
Kopecky, K.J.2
Meshinchi, S.3
-
53
-
-
0141455981
-
FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress
-
Libura M, Asnafi V, Tu A, et al. (2003) FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress. Blood 102:2198-204.
-
(2003)
Blood
, vol.102
, pp. 2198-204
-
-
Libura, M.1
Asnafi, V.2
Tu, A.3
-
54
-
-
0024990090
-
N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance
-
Radich JP, Kopecky KJ,Willman CL, et al. (1990) N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance. Blood 76:801-7.
-
(1990)
Blood
, vol.76
, pp. 801-7
-
-
Radich, J.P.1
Kopecky, K.J.2
Willman, C.L.3
-
55
-
-
0035383768
-
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia
-
Stirewalt DL, Kopecky KJ, Meshinchi S, et al. (2001) FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia. Blood 97:3589-95.
-
(2001)
Blood
, vol.97
, pp. 3589-95
-
-
Stirewalt, D.L.1
Kopecky, K.J.2
Meshinchi, S.3
-
56
-
-
17344371122
-
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up
-
Padua RA, Guinn BA, Al-Sabah AI, et al. (1998) RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up. Leukemia 12:887-92.
-
(1998)
Leukemia
, vol.12
, pp. 887-92
-
-
Padua, R.A.1
Guinn, B.A.2
Al-Sabah, A.I.3
-
57
-
-
0032896457
-
RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)
-
Flotho C,Valcamonica S, Mach-Pascual S, et al. (1999) RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 13:32-7.
-
(1999)
Leukemia
, vol.13
, pp. 32-7
-
-
Flotho, C.1
Valcamonica, S.2
Mach-Pascual, S.3
-
58
-
-
0024998851
-
RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia
-
Hirsch-Ginsberg C, LeMaistre AC, Kantarjian H, et al. (1990) RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia. Blood 76:1214-9.
-
(1990)
Blood
, vol.76
, pp. 1214-9
-
-
Hirsch-Ginsberg, C.1
LeMaistre, A.C.2
Kantarjian, H.3
-
59
-
-
0031937682
-
The molecular pathophysiology of myeloid leukaemias: Ras revisited
-
Byrne JL, Marshall CJ. (1998) The molecular pathophysiology of myeloid leukaemias: Ras revisited. Br J Haematol 100:256-64.
-
(1998)
Br J Haematol
, vol.100
, pp. 256-64
-
-
Byrne, J.L.1
Marshall, C.J.2
-
60
-
-
33646575624
-
Implications of NRAS mutations in AML: a study of 2502 patients
-
Bacher U, Haferlach T, Schoch C, KernW, Schnittger S. (2006) Implications of NRAS mutations in AML: a study of 2502 patients. Blood 107:3847-53.
-
(2006)
Blood
, vol.107
, pp. 3847-53
-
-
Bacher, U.1
Haferlach, T.2
Schoch, C.3
Kern, W.4
Schnittger, S.5
-
61
-
-
0025190309
-
FMS mutations in myelodysplastic, leukemic, and normal subjects
-
USA
-
Ridge SA,Worwood M, Oscier D, Jacobs A, Padua RA. (1990) FMS mutations in myelodysplastic, leukemic, and normal subjects. Proc Natl Acad Sci U S A 87:1377-80.
-
(1990)
Proc Natl Acad Sci
, vol.87
, pp. 1377-80
-
-
Ridge, S.A.1
Worwood, M.2
Oscier, D.3
Jacobs, A.4
Padua, R.A.5
-
62
-
-
0032989226
-
c-kit protooncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia
-
Gari M, Goodeve A,Wilson G, et al. (1999) c-kit protooncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia. Br J Haematol 105:894-900.
-
(1999)
Br J Haematol
, vol.105
, pp. 894-900
-
-
Gari, M.1
Goodeve, A.2
Wilson, G.3
-
63
-
-
7844228063
-
Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val
-
Sperr WR, Walchshofer S, Horny HP, et al. (1998) Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val. Br J Haematol 103:740-9.
-
(1998)
Br J Haematol
, vol.103
, pp. 740-9
-
-
Sperr, W.R.1
Walchshofer, S.2
Horny, H.P.3
-
64
-
-
33344465478
-
KITD816 mutations in AML1-ETO-positiveAMLare associated with impaired event-free and overall survival
-
Schnittger S, Kohl TM, Haferlach T, et al. (2006) KITD816 mutations in AML1-ETO-positiveAMLare associated with impaired event-free and overall survival. Blood 107:1791-9.
-
(2006)
Blood
, vol.107
, pp. 1791-9
-
-
Schnittger, S.1
Kohl, T.M.2
Haferlach, T.3
-
65
-
-
28444473100
-
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations
-
Dohner K, Schlenk RF, Habdank M, et al. (2005) Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood 106:3740-6.
-
(2005)
Blood
, vol.106
, pp. 3740-6
-
-
Dohner, K.1
Schlenk, R.F.2
Habdank, M.3
-
66
-
-
41949090673
-
The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia
-
Gale RE, Green C, Allen C, et al. (2008) The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. Blood 111:2776-84.
-
(2008)
Blood
, vol.111
, pp. 2776-84
-
-
Gale, R.E.1
Green, C.2
Allen, C.3
-
67
-
-
42949142189
-
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
-
Schlenk RF, Dohner K, Krauter J, et al. (2008) Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. New Engl J Med 358:1909-18.
-
(2008)
New Engl J Med
, vol.358
, pp. 1909-18
-
-
Schlenk, R.F.1
Dohner, K.2
Krauter, J.3
-
68
-
-
28444449081
-
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype
-
Schnittger S, Schoch C, KernW, et al. (2005) Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood 106:3733-9.
-
(2005)
Blood
, vol.106
, pp. 3733-9
-
-
Schnittger, S.1
Schoch, C.2
Ker, W.3
-
69
-
-
33646557337
-
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
-
Thiede C, Koch S, Creutzig E, et al. (2006) Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood 107:4011-20.
-
(2006)
Blood
, vol.107
, pp. 4011-20
-
-
Thiede, C.1
Koch, S.2
Creutzig, E.3
-
70
-
-
67651065502
-
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
-
Abdel-Wahab O, Mullally A, Hedvat C, et al. (2009) Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 114:144-7.
-
(2009)
Blood
, vol.114
, pp. 144-7
-
-
Abdel-Wahab, O.1
Mullally, A.2
Hedvat, C.3
-
71
-
-
67650924270
-
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
-
Tefferi A, Lim KH, Abdel-Wahab O, et al. (2009) Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML. Leukemia 23:1343-5.
-
(2009)
Leukemia
, vol.23
, pp. 1343-5
-
-
Tefferi, A.1
Lim, K.H.2
Abdel-Wahab, O.3
-
73
-
-
70350438115
-
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)
-
Kosmider O, Gelsi-Boyer V, Cheok M, et al. (2009) TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs). Blood 114:3285-91.
-
(2009)
Blood
, vol.114
, pp. 3285-91
-
-
Kosmider, O.1
Gelsi-Boyer, V.2
Cheok, M.3
-
74
-
-
1442356729
-
CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations
-
Frohling S, Schlenk RF, Stolze I, et al. (2004) CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. J Clin Oncol 22:624-33.
-
(2004)
J Clin Oncol
, vol.22
, pp. 624-33
-
-
Frohling, S.1
Schlenk, R.F.2
Stolze, I.3
-
75
-
-
0037108111
-
Favorable prognostic significance of CEBPAmutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)
-
Preudhomme C, Sagot C, Boissel N, et al. (2002) Favorable prognostic significance of CEBPAmutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA). Blood 100:2717-23.
-
(2002)
Blood
, vol.100
, pp. 2717-23
-
-
Preudhomme, C.1
Sagot, C.2
Boissel, N.3
-
77
-
-
0030737629
-
High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse longterm outcome
-
Bergmann L, Miething C, Maurer U, et al. (1997) High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse longterm outcome. Blood 90:1217-25.
-
(1997)
Blood
, vol.90
, pp. 1217-25
-
-
Bergmann, L.1
Miething, C.2
Maurer, U.3
-
78
-
-
0032522974
-
Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance
-
King-Underwood L, Pritchard-Jones K. (1998)Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance. Blood 91:2961-8.
-
(1998)
Blood
, vol.91
, pp. 2961-8
-
-
King-Underwood, L.1
Pritchard-Jones, K.2
-
79
-
-
33847238455
-
Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML
-
author reply 2
-
Summers K, Stevens J, Kakkas I, et al. (2007)Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML. Leukemia 21(3): 550-1; author reply 2.
-
(2007)
Leukemia
, vol.21
, Issue.3
, pp. 550-1
-
-
Summers, K.1
Stevens, J.2
Kakkas, I.3
-
80
-
-
23844458023
-
Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia
-
Weisser M, KernW, Rauhut S, et al. (2005) Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia. Leukemia 19:1416-23.
-
(2005)
Leukemia
, vol.19
, pp. 1416-23
-
-
Weisser, M.1
Kern, W.2
Rauhut, S.3
-
81
-
-
0028942107
-
A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells
-
Tse W, Zhu W, Chen HS, Cohen A. (1995) A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. Blood 85:650-6.
-
(1995)
Blood
, vol.85
, pp. 650-6
-
-
Tse, W.1
Zhu, W.2
Chen, H.S.3
Cohen, A.4
-
82
-
-
65649120444
-
Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics
-
Strunk CJ, Platzbecker U, Thiede C, et al. (2009) Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics. Am J Haematol 84:308-9.
-
(2009)
Am J Haematol
, vol.84
, pp. 308-9
-
-
Strunk, C.J.1
Platzbecker, U.2
Thiede, C.3
-
83
-
-
12744279347
-
Increased AF1q gene expression in highrisk myelodysplastic syndrome
-
Tse W, Joachim Deeg H, Stirewalt D, et al. (2005) Increased AF1q gene expression in highrisk myelodysplastic syndrome. Br J Haematol 128:218-20.
-
(2005)
Br J Haematol
, vol.128
, pp. 218-20
-
-
Tse, W.1
Joachim Deeg, H.2
Stirewalt, D.3
-
84
-
-
8644238287
-
Elevated expression of the AF1q gene, anMLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia
-
TseW, Meshinchi S, Alonzo TA, et al. (2004) Elevated expression of the AF1q gene, anMLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia. Blood 104:3058-63.
-
(2004)
Blood
, vol.104
, pp. 3058-63
-
-
Tse, W.1
Meshinchi, S.2
Alonzo, T.A.3
-
85
-
-
0041440085
-
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B study
-
Baldus CD, Tanner SM, Ruppert AS, et al. (2003) BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B study. Blood 102:1613-8.
-
(2003)
Blood
, vol.102
, pp. 1613-8
-
-
Baldus, C.D.1
Tanner, S.M.2
Ruppert, A.S.3
-
86
-
-
45949110015
-
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study
-
Langer C, Radmacher MD, Ruppert AS, et al. (2008) High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study. Blood 111:5371-9.
-
(2008)
Blood
, vol.111
, pp. 5371-9
-
-
Langer, C.1
Radmacher, M.D.2
Ruppert, A.S.3
-
87
-
-
33644830601
-
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study
-
Marcucci G, Baldus CD, Ruppert AS, et al. (2005) Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. J Clin Oncol 23:9234-42.
-
(2005)
J Clin Oncol
, vol.23
, pp. 9234-42
-
-
Marcucci, G.1
Baldus, C.D.2
Ruppert, A.S.3
-
88
-
-
38949123096
-
Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML
-
Gondek LP, Tiu R, O'Keefe CL, et al. (2008) Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Blood 111:1534-42.
-
(2008)
Blood
, vol.111
, pp. 1534-42
-
-
Gondek, L.P.1
Tiu, R.2
O'Keefe, C.L.3
-
89
-
-
44449151696
-
Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia
-
Gupta M, Raghavan M, Gale RE, et al. (2008) Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia. Genes, Chromosomes Cancer 47:729-39.
-
(2008)
Genes, Chromosomes Cancer
, vol.47
, pp. 729-39
-
-
Gupta, M.1
Raghavan, M.2
Gale, R.E.3
-
90
-
-
34249733270
-
DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups
-
Suela J, Alvarez S, Cifuentes F, et al. (2007) DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups. Leukemia 21:1224-31.
-
(2007)
Leukemia
, vol.21
, pp. 1224-31
-
-
Suela, J.1
Alvarez, S.2
Cifuentes, F.3
-
91
-
-
55549101623
-
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
-
Ley TJ, Mardis ER, Ding L, et al. (2008) DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456:66-72.
-
(2008)
Nature
, vol.456
, pp. 66-72
-
-
Ley, T.J.1
Mardis, E.R.2
Ding, L.3
-
92
-
-
70149093912
-
Recurring mutations found by sequencing an acute myeloid leukemia genome
-
Mardis ER, Ding L, Dooling DJ, et al. (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. New Engl J Med 361:1058-66.
-
(2009)
New Engl J Med
, vol.361
, pp. 1058-66
-
-
Mardis, E.R.1
Ding, L.2
Dooling, D.J.3
-
93
-
-
18544375333
-
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
-
Armstrong SA, Staunton JE, Silverman LB, et al. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30:41-7.
-
(2002)
Nat Genet
, vol.30
, pp. 41-7
-
-
Armstrong, S.A.1
Staunton, J.E.2
Silverman, L.B.3
-
94
-
-
17744366190
-
AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes
-
Haferlach T, Kohlmann A, Schnittger S, et al. (2005) AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes. Genes, Chromosomes Cancer 43:113-27.
-
(2005)
Genes, Chromosomes Cancer
, vol.43
, pp. 113-27
-
-
Haferlach, T.1
Kohlmann, A.2
Schnittger, S.3
-
95
-
-
18444388287
-
Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles
-
USA
-
Schoch C, Kohlmann A, Schnittger S, et al. (2002) Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci U S A 99:10008-13.
-
(2002)
Proc Natl Acad Sci
, vol.99
, pp. 10008-13
-
-
Schoch, C.1
Kohlmann, A.2
Schnittger, S.3
-
96
-
-
23644438883
-
Global approach to the diagnosis of leukemia using gene expression profiling
-
Haferlach T, Kohlmann A, Schnittger S, et al. (2005) Global approach to the diagnosis of leukemia using gene expression profiling. Blood 106:1189-98.
-
(2005)
Blood
, vol.106
, pp. 1189-98
-
-
Haferlach, T.1
Kohlmann, A.2
Schnittger, S.3
-
97
-
-
0035970039
-
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics
-
USA
-
Virtaneva K, Wright FA, Tanner SM, et al. (2001) Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A 98:1124-9.
-
(2001)
Proc Natl Acad Sci
, vol.98
, pp. 1124-9
-
-
Virtaneva, K.1
Wright, F.A.2
Tanner, S.M.3
-
98
-
-
16544369516
-
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia
-
Bullinger L, Dohner K, Bair E, et al. (2004) Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. New Engl J Med 350:1605-16.
-
(2004)
New Engl J Med
, vol.350
, pp. 1605-16
-
-
Bullinger, L.1
Dohner, K.2
Bair, E.3
-
99
-
-
11144358111
-
Prognostically useful gene-expression profiles in acute myeloid leukemia
-
Valk PJ, Verhaak RG, Beijen MA, et al. (2004) Prognostically useful gene-expression profiles in acute myeloid leukemia. New Engl J Med 350:1617-28.
-
(2004)
New Engl J Med
, vol.350
, pp. 1617-28
-
-
Valk, P.J.1
Verhaak, R.G.2
Beijen, M.A.3
-
100
-
-
7244236503
-
Gene expression profiles at diagnosis in de novo childhoodAMLpatients identify FLT3 mutations with good clinical outcomes
-
Lacayo NJ, Meshinchi S, Kinnunen P, et al. (2004) Gene expression profiles at diagnosis in de novo childhoodAMLpatients identify FLT3 mutations with good clinical outcomes. Blood 104:2646-54.
-
(2004)
Blood
, vol.104
, pp. 2646-54
-
-
Lacayo, N.J.1
Meshinchi, S.2
Kinnunen, P.3
-
101
-
-
20144381877
-
Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype
-
Neben K, Schnittger S, Brors B, et al. (2005) Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype. Oncogene 24:1580-8.
-
(2005)
Oncogene
, vol.24
, pp. 1580-8
-
-
Neben, K.1
Schnittger, S.2
Brors, B.3
-
102
-
-
23044459136
-
Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance
-
Alcalay M, Tiacci E, Bergomas R, et al. (2005) Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood 106:899-902.
-
(2005)
Blood
, vol.106
, pp. 899-902
-
-
Alcalay, M.1
Tiacci, E.2
Bergomas, R.3
-
103
-
-
28444446313
-
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance
-
Verhaak RG, Goudswaard CS, van Putten W, et al. (2005) Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood 106:3747-54.
-
(2005)
Blood
, vol.106
, pp. 3747-54
-
-
Verhaak, R.G.1
Goudswaard, C.S.2
van Putten, W.3
-
104
-
-
33745957993
-
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction
-
Wilson CS, Davidson GS, Martin SB, et al. (2006)Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction. Blood 108:685-96.
-
(2006)
Blood
, vol.108
, pp. 685-96
-
-
Wilson, C.S.1
Davidson, G.S.2
Martin, S.B.3
-
105
-
-
57449103508
-
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia
-
Metzeler KH,HummelM,Bloomfield CD, et al. (2008) An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood 112:4193-201.
-
(2008)
Blood
, vol.112
, pp. 4193-201
-
-
Metzeler, K.H.1
Hummel, M.2
Bloomfield, C.D.3
-
106
-
-
33747420007
-
Independent confirmation of a prognostic gene- expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study
-
Radmacher MD,Marcucci G, Ruppert AS, et al. (2006) Independent confirmation of a prognostic gene- expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study. Blood 108:1677-83.
-
(2006)
Blood
, vol.108
, pp. 1677-83
-
-
Radmacher, M.D.1
Marcucci, G.2
Ruppert, A.S.3
-
107
-
-
36549022557
-
Identification of genes with abnormal expression changes in acute myeloid leukemia
-
Stirewalt DL, Meshinchi S, Kopecky KJ, et al. (2008) Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes, Chromosomes and Cancer 47:8-20.
-
(2008)
Genes, Chromosomes and Cancer
, vol.47
, pp. 8-20
-
-
Stirewalt, D.L.1
Meshinchi, S.2
Kopecky, K.J.3
-
108
-
-
33646437227
-
Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia
-
Steinbach D, Schramm A, Eggert A, et al. (2006) Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia. Clin Cancer Res 12:2434-41.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 2434-41
-
-
Steinbach, D.1
Schramm, A.2
Eggert, A.3
-
109
-
-
0347444723
-
MicroRNAs: genomics, biogenesis, mechanism, and function
-
Bartel DP. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-97.
-
(2004)
Cell
, vol.116
, pp. 281-97
-
-
Bartel, D.P.1
-
110
-
-
34548230885
-
Ultraconserved regions encodingncRNAs are altered in human leukemias and carcinomas
-
Calin GA, Liu CG, Ferracin M, et al. (2007) Ultraconserved regions encodingncRNAs are altered in human leukemias and carcinomas. Cancer Cell 12:215-29.
-
(2007)
Cancer Cell
, vol.12
, pp. 215-29
-
-
Calin, G.A.1
Liu, C.G.2
Ferracin, M.3
-
111
-
-
38049123402
-
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia
-
USA
-
Mi S, Lu J, Sun M, et al. (2007) MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci U S A 104:19971-6.
-
(2007)
Proc Natl Acad Sci
, vol.104
, pp. 19971-6
-
-
Mi, S.1
Lu, J.2
Sun, M.3
-
112
-
-
42449141513
-
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia
-
Garzon R, Volinia S, Liu CG, et al. (2008) MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111:3183-9.
-
(2008)
Blood
, vol.111
, pp. 3183-9
-
-
Garzon, R.1
Volinia, S.2
Liu, C.G.3
-
113
-
-
46749108531
-
MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia
-
Jongen-Lavrencic M, Sun SM, Dijkstra MK, Valk PJ, Lowenberg B. (2008) MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 111:5078-85.
-
(2008)
Blood
, vol.111
, pp. 5078-85
-
-
Jongen-Lavrencic, M.1
Sun, S.M.2
Dijkstra, M.K.3
Valk, P.J.4
Lowenberg, B.5
-
114
-
-
47749117212
-
Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia
-
Dixon-McIver A, East P, Mein CA, et al. (2008) Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PloS ONE 3:e2141.
-
(2008)
PloS ONE
, vol.3
-
-
Dixon-McIver, A.1
East, P.2
Mein, C.A.3
-
115
-
-
55749099505
-
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
-
USA
-
Li Z, Lu J, Sun M, et al. (2008) Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci U S A 105:15535-40.
-
(2008)
Proc Natl Acad Sci
, vol.105
, pp. 15535-40
-
-
Li, Z.1
Lu, J.2
Sun, M.3
-
116
-
-
41649119008
-
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin
-
Garzon R, Garofalo M, Martelli MP, et al. (2008) Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A 105:3945-50.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 3945-50
-
-
Garzon, R.1
Garofalo, M.2
Martelli, M.P.3
-
117
-
-
42949083345
-
MicroRNA expression in cytogenetically normal acute myeloid leukemia
-
Marcucci G, Radmacher MD, Maharry K, et al. (2008) MicroRNA expression in cytogenetically normal acute myeloid leukemia. New Engl J Med 358:1919-28.
-
(2008)
New Engl J Med
, vol.358
, pp. 1919-28
-
-
Marcucci, G.1
Radmacher, M.D.2
Maharry, K.3
-
118
-
-
0036144048
-
DNA methylation patterns and epigenetic memory
-
Bird A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16:6-21.
-
(2002)
Genes Dev
, vol.16
, pp. 6-21
-
-
Bird, A.1
-
119
-
-
0035839136
-
Translating the histone code
-
Jenuwein T, Allis CD. (2001) Translating the histone code. Science 293:1074-80.
-
(2001)
Science
, vol.293
, pp. 1074-80
-
-
Jenuwein, T.1
Allis, C.D.2
-
120
-
-
0036274359
-
The fundamental role of epigenetic events in cancer
-
Jones PA, Baylin SB. (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-28.
-
(2002)
Nat Rev Genet
, vol.3
, pp. 415-28
-
-
Jones, P.A.1
Baylin, S.B.2
-
121
-
-
60849089645
-
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
-
Jiang Y, Dunbar A, Gondek LP, et al. (2009) Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood 113:1315-25.
-
(2009)
Blood
, vol.113
, pp. 1315-25
-
-
Jiang, Y.1
Dunbar, A.2
Gondek, L.P.3
-
122
-
-
70350720044
-
MDSand secondary AML display unique patterns and abundance of aberrant DNA methylation
-
Figueroa ME, Skrabanek L, Li Y, et al. (2009)MDSand secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood 114:3448-58.
-
(2009)
Blood
, vol.114
, pp. 3448-58
-
-
Figueroa, M.E.1
Skrabanek, L.2
Li, Y.3
-
123
-
-
33846640626
-
Insight into the molecular pathogenesis of myeloid malignancies
-
Haferlach T, Bacher U, Haferlach C, Kern W, Schnittger S. (2007) Insight into the molecular pathogenesis of myeloid malignancies. Cur Opin Hematol 14:90-7.
-
(2007)
Cur Opin Hematol
, vol.14
, pp. 90-7
-
-
Haferlach, T.1
Bacher, U.2
Haferlach, C.3
Kern, W.4
Schnittger, S.5
-
124
-
-
13244268335
-
Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics
-
Marcucci G, Mrozek K, Bloomfield CD. (2005) Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics. Cur Opin Hematol 12:68-75.
-
(2005)
Cur Opin Hematol
, vol.12
, pp. 68-75
-
-
Marcucci, G.1
Mrozek, K.2
Bloomfield, C.D.3
-
125
-
-
33846230449
-
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?
-
Mrozek K, Marcucci G, Paschka P, Whitman SP, Bloomfield CD. (2007) Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?. Blood 109:431-48.
-
(2007)
Blood
, vol.109
, pp. 431-48
-
-
Mrozek, K.1
Marcucci, G.2
Paschka, P.3
Whitman, S.P.4
Bloomfield, C.D.5
-
126
-
-
0041737454
-
Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia
-
Meshinchi S, Stirewalt DL, Alonzo TA, et al. (2003) Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia. Blood 102:1474-9.
-
(2003)
Blood
, vol.102
, pp. 1474-9
-
-
Meshinchi, S.1
Stirewalt, D.L.2
Alonzo, T.A.3
|